Filing Details

Accession Number:
0001209191-20-000785
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-03 16:07:13
Reporting Period:
2020-01-02
Accepted Time:
2020-01-03 16:07:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465278 P Joseph Hagan C/O Regulus Therapeutics Inc.
10628 Science Center Dr., #225
San Diego CA 92121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-02 8,345 $0.97 235,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person on 2/5/2019. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.